ROGER CRYSTAL

Insider Reports History

Location
New York, NY
Signature
/s/ Mark Sullivan, Attorney-in-Fact for Roger Crystal
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ROGER CRYSTAL:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mind Medicine (MindMed) Inc. Director Stock Option (Right to Buy) 75,187 12 Jun 2025 Direct
OPIANT PHARMACEUTICALS, INC. Chief Executive Officer, Director, 10%+ Owner Common Stock 0 $20.00 02 Mar 2023 Direct
OPIANT PHARMACEUTICALS, INC. Chief Executive Officer, Director, 10%+ Owner Option 0 02 Mar 2023 Direct
OPIANT PHARMACEUTICALS, INC. Chief Executive Officer, Director, 10%+ Owner Stock Option (right to buy) 0 $10.00 02 Mar 2023 Direct

Insider Reports Filed by ROGER CRYSTAL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MNMD Mind Medicine (MindMed) Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 16:30
MNMD Mind Medicine (MindMed) Inc. 10 Jun 2024 1 $0 4 Director 12 Jun 2024, 16:13
MNMD Mind Medicine (MindMed) Inc. 21 Jun 2023 2 $0 4 Director 23 Jun 2023, 17:53
/report/000138550823000069-crystal-roger-2023-03-02 OPIANT PHARMACEUTICALS, INC. 02 Mar 2023 12 -$1,742,120 4 Chief Executive Officer, Director, 10%+ Owner 03 Mar 2023, 08:18
/report/000138550823000034-crystal-roger-2023-01-27 OPIANT PHARMACEUTICALS, INC. 27 Jan 2023 1 -$27,513 4 Chief Executive Officer, Director, 10%+ Owner 31 Jan 2023, 15:22
/report/000138550823000018-crystal-roger-2023-01-09 OPIANT PHARMACEUTICALS, INC. 09 Jan 2023 1 -$23,897 4 Chief Executive Officer, Director, 10%+ Owner 09 Jan 2023, 16:09
/report/000138550823000005-crystal-roger-2023-01-05 OPIANT PHARMACEUTICALS, INC. 05 Jan 2023 1 -$101,586 4 Chief Executive Officer, Director, 10%+ Owner 05 Jan 2023, 15:52
MNMD Mind Medicine (MindMed) Inc. 11 Aug 2022 3 $0 4 Director 15 Aug 2022, 21:55
MNMD Mind Medicine (MindMed) Inc. 11 Aug 2022 0 $0 3 Director 15 Aug 2022, 21:05
/report/000138550822000109-crystal-roger-2022-07-14 OPIANT PHARMACEUTICALS, INC. 14 Jul 2022 1 -$24,953 4 Chief Executive Officer, Director, 10%+ Owner 15 Jul 2022, 16:03
/report/000138550822000103-crystal-roger-2022-06-27 OPIANT PHARMACEUTICALS, INC. 27 Jun 2022 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 29 Jun 2022, 16:06
/report/000138550822000025-crystal-roger-2022-01-27 OPIANT PHARMACEUTICALS, INC. 27 Jan 2022 1 -$52,169 4 Chief Executive Officer, Director, 10%+ Owner 27 Jan 2022, 15:03
/report/000138550822000020-crystal-roger-2022-01-10 OPIANT PHARMACEUTICALS, INC. 10 Jan 2022 1 -$32,258 4 Chief Executive Officer, Director, 10%+ Owner 12 Jan 2022, 15:29
/report/000138550822000008-crystal-roger-2022-01-04 OPIANT PHARMACEUTICALS, INC. 04 Jan 2022 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 05 Jan 2022, 15:15
/report/000138550821000134-crystal-roger-2021-09-16 OPIANT PHARMACEUTICALS, INC. 16 Sep 2021 1 +$2,344 4 Chief Executive Officer, Director, 10%+ Owner 16 Sep 2021, 16:12